Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 16 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 7632503

    Method of treating a muscle-related condition with modified IGF1 polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  2. US 7632932

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  3. US 7622556

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  4. US 7622105

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  5. US 7612188

    Modified vitamin K. dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  6. US 7582744

    Chemically modified oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  7. US 7579451

    Oligonucleotides comprising a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

  8. US 7576076

    Modified pyrimidine glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  9. US 7572764

    Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

    State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  10. US 7553935

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  11. US 7553934

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  12. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  13. US 7524499

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  14. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  15. US 7488804

    Modified fusion molecules for treatment of allergic disease

    The Regents of the University of California · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  16. US 7479551

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  17. US 7476721

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  18. US 7374758

    Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  19. US 7374757

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  20. US 7355018

    Modified IGF1 polypeptides with increased stability and potency

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  21. US 7341726

    Modified HCV peptide immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted

  22. US 7314917

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  23. US 7309694

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  24. US 7303746

    Methods of treating eye disorders with modified chimeric polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.